|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Operating expenses: | ||||
| Research and development | ||||
| General and administrative | ||||
| Total operating expenses | ||||
| Operating loss | ||||
| Other income (expense): | ||||
| Interest income | ||||
| Other (expense) income, net | ||||
| Total other income, net | ||||
| Net loss before income tax | ||||
| Income tax (expense) benefit | ||||
| Net loss | ||||
| Net loss per share, basic | ||||
| Net loss per share, diluted | ||||
| Weighted-average common shares outstanding, basic | ||||
| Weighted-average common shares outstanding, diluted | ||||
| Other comprehensive (loss) income: | ||||
| Cumulative translation adjustment arising during the period | ||||
| Unrealized (loss) gain on marketable securities | ||||
| Comprehensive loss |
Loading...